FUNDINNO PLUS+ Secures 1.3 Billion Yens for Innovative Proton Beam Therapy Device

FUNDINNO, a company headquartered in Minato, Tokyo, has recently announced the successful acquisition of approximately 1.3 billion yens through its service FUNDINNO PLUS+. This service enables special investors to make direct investments, promoting the advancement of innovative medical technology.

Be-dots Medical, based in Edogawa, Tokyo, is the recipient of these funds and is pioneering the development, manufacturing, and sales of proton beam therapy devices. Traditionally, these devices were large and cumbersome, similar in size to a three-story building. However, through groundbreaking technology, Be-dots Medical has managed to reduce the height by one-third and the weight by a factor of ten. This significant downsizing allows for more cost-effective installations in urban areas where space is limited.

In April 2023, Be-dots Medical reached a collaboration agreement with the Edogawa Hospital Group to establish a Proton Beam Cancer Treatment Center at Edogawa Medicare Hospital in Tokyo. This center will be the first of its kind in the metropolis, significantly expanding treatment options for patients who previously had to travel to other prefectures for similar care. The aim is to ensure that all patients in Japan have access to proton beam therapy as a standard part of their treatment options.

Comments from Be-dots Medical CEO

Mr. Takuji Furukawa, the CEO of Be-dots Medical, expressed gratitude for the support received through FUNDINNO PLUS+. He stated, “We are deeply thankful for the generous backing from numerous investors. This funding not only helps us financially but also provides a unique opportunity to connect with individuals who share our vision for the future of cancer treatment. We hope this initiative will heighten awareness about our company among a wider audience.”

What is FUNDINNO PLUS+?

FUNDINNO PLUS+ is a service that facilitates significant funding for venture companies, while providing investors with opportunities to invest in promising unlisted firms that are nearing an initial public offering (IPO). Through this service, registered special investors can gain access to investment opportunities in growing startups, making it an appealing option due to the balance of risks and potential returns.

About FUNDINNO

FUNDINNO aims to democratize the venture market in Japan by bridging gaps in information and opportunities, thus enabling all entrepreneurs and investors to challenge the status quo fairly. The vision is to empower entrepreneurs by providing diverse options and conveying investor support to them. The platform's goal is to pave the way to a brighter future for determined individuals.

Additional Services by FUNDINNO

- FUNDINNO Market: This is Japan's first secondary market for trading unlisted stocks online, encouraging investor engagement and liquidity.
- FUNDOR: A comprehensive management platform designed for venture companies, allowing them to manage stakeholders, board meetings, financial operations, and investor communications all in one place.

Conclusion

FUNDINNO’s efforts in supporting innovative startups like Be-dots Medical highlight the potential of collaboration between modern investment avenues and advancements in medical technology. By allowing more players to enter the investment space, both patients and startups stand to benefit significantly, promoting a future where innovative treatments like proton beam therapy become accessible to all patients nationwide. As this market continues to evolve, the partnerships formed through services like FUNDINNO PLUS+ will be instrumental in shaping the next generation of medical care in Japan.